This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Avandia News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Avandia News

  • Clash of options leaves Deutsche Telekom struggling 3 Jul 2009 04:22 GMT
    ... Sanofi-Aventis' diabetes blockbuster Lantus depressed the French pharmaceutical company's share price sharply last week. Or ... the cardiac side effects of GlaxoSmithKline's diabetes drug Avandia two years ago, which cut sales sharply. ...

  • 5 myths about America's ailing health-care system 2 Jul 2009 08:12 GMT
    ... the Americans got twice as many high-tech treatments. Moreover, the quality of health care is ... Tracking the rate of heart attacks from drugs such as Avandia is key to ensuring safe pharmaceuticals. Let's ...

  • UPDATE 3-US FDA plays down cancer link with Sanofi's Lantus 1 Jul 2009 21:02 GMT
    ... 1 (Reuters) - The U.S. Food and Drug Administration on Wednesday cast doubt on recent ... using the product and turn to rival treatments such as Novo Nordisk's long-acting insulin Levemir. ... drop seen in global sales of GlaxoSmithKline's Avandia, which was linked to heart attack risk ...

  • FDA plays down cancer link with Sanofi's Lantus 1 Jul 2009 20:40 GMT
    ... YORK/WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Wednesday cast doubt on recent ... using the product and turn to rival treatments such as Novo Nordisk's long-acting insulin Levemir. ... drop seen in global sales of GlaxoSmithKline's Avandia, which was linked to heart attack risk ...

  • Master Stem Cell for Human Heart Identified 1 Jul 2009 18:50 GMT
    ... might also help in the development of drugs with fewer heart-related side effects as well ... drugs, such as Herceptin (for cancer) and Avandia (for ), have heart-related side effects. The ... Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & ...

  • UPDATE 2-US FDA questions cancer link with Sanofi's Lantus 1 Jul 2009 16:02 GMT
    ... 1 (Reuters) - The U.S. Food and Drug Administration on Wednesday cast doubt on recent ... using the product and turn to rival treatments such as Novo Nordisk's ( Lantus is ... in global sales of GlaxoSmithKline's ( ) Avandia, which was linked to heart attack risk ...

  • Alogliptin delayed; cancer concerns with insulin glargine 30 Jun 2009 20:51 GMT
    ... Japan -As expected, the US Food and Drug Administration has turned away the investigational diabetes ... this field, especially the thiazolidinediones, including rosiglitazone (Avandia, GlaxoSmithKline). Takeda was informed in March that ... complete response letter for alogliptin, an investigational treatment for type 2 diabetes [press release]. June ...

  • Woman Suffers Fractures After Taking Avandia 30 Jun 2009 15:10 GMT
    ... Rocky Mount, NC: Avandia side effects allegedly cover a wide range ... sustaining fractures. "I was on 2 different medications, but Avandia is the one that I ... rosiglitazone maleate) belongs to a class of drugs known as thiazolidinediones. [ ...

  • Sanofi-Aventis Stock Recovering After Lantus Leak 30 Jun 2009 08:11 GMT
    ... were about to be published in a medical journal identifying a suspected higher risk of ... controversial study of GlaxoSmithKline's ( ) diabetes pill Avandia a couple of years ago, so it ...

  • For the RECORD, Many Say Avandia Study is Flawed 29 Jun 2009 19:10 GMT
    ... For the RECORD, Many Say Avandia Study i.. For the RECORD, Many Say ... as safe as other Type 2 diabetes drugs with regard to risk for cardiovascular death ... Home is also a professor of diabetes medicine in the United Kingdom. However, according to ...

  • Sanofi rivals to gain as Lantus faces sales drop 29 Jun 2009 10:00 GMT
    ... Correspondent LONDON, June 29 (Reuters) - Rival drugmakers look set to gain from a possible ... Merck & Co, which sells the DPP-4 treatment Januvia; and AstraZeneca and Bristol-Myers Squibb, which ... past scares, involving drugs such as GlaxoSmithKline's Avandia and Merck and Schering-Plough's Vytorin, suggests many ...

  • How Bad Is Sanofi's Safety Scare? 28 Jun 2009 10:11 GMT
    ... Shares of the French drugmaker are getting pummeled over at least three ... call soon on its similar one-a-day diabetes treatment, Victoza. David Kliff, a Type-2 diabetic who ... lynching as it did when the (GlaxoSmithKline) Avandia controversy came to light that cooler heads ...

  • Looking for a Sliver of the Me-Too Pie 27 Jun 2009 07:52 GMT
    ... the big question is whether the diabetes drug will give the drugmakers any appreciable revenue. Yesterday, ... the wake of GlaxoSmithKline 's (NYSE: GSK) Avandia issues. The companies skirted around the issue ... over Eli Lilly (NYSE: LLY) and Amylin Pharmaceuticals ' (Nasdaq: AMLN) Byetta, but it's in ...

  • Sanofi says new data inconclusive on Lantus risk 26 Jun 2009 22:13 GMT
    ... The French drugmaker has been rocked in the past two ... shortly to be published in a major medical journal. Its stock fell 8 percent on ... when safety concerns over its diabetes drug Avandia saw prescriptions tumble almost 50 percent in ...

  • Sanofi says new data inconclusive on Lantus risk 26 Jun 2009 22:12 GMT
    ... The French drugmaker has been rocked in the past two ... shortly to be published in a major medical journal. Its stock fell 8 percent on ... when safety concerns over its diabetes drug Avandia saw prescriptions tumble almost 50 percent in ...


1 - 15 / 63      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS AVANDIA NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
Contact Lens King.comAdvertise Here
 

Take This Poll

What technology holds the greatest potential for production of environmentally friendly cars that can be affordable to regular car buyers? (Jun. 10, 2009)








 

BUSINESS PROMOTION SERVICES

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

EIN Advertising · Place banner ads on EIN News industry specific publications and daily e-mail news alerts.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

Educational Services · Students, teachers and other academic workers are eligible for free memberships.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.


EIN News Copyright © 1995 - 2009 All Rights Reserved. www.einnews.info | User Agreement | Privacy Policy | Contact